Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Diphenylcyclopropenone

Phase 1Small molecule

RRockefeller University

1

Indications

6

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Skin DiseasesActive, not recruiting

Skin DiseasesPhase 1

Active, not recruiting

Timeline

Expected Milestones

Q4 2027

Phase 1Active, not recruiting

Skin Diseases

NCT05020496

Clinical

Trials by Indication[1]

Metastases1 trial

Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)

Completed·RRockefeller University·Phase 1·NCT01711684·6 enrolled

Vitiligo1 trial

Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo

Completed·—·Phase 4·NCT04775979·20 enrolled

Alopecia Areata1 trial

DPCP for the Treatment of Alopecia Areata

Terminated·UUniversity of Minnesota·Phase 3·NCT03651752·4 enrolled

Immunosuppression1 trial

Effect of RANKL Inhibition on UV-induced Immunosuppression

Completed·IInnovaderm Research Inc.·Phase 1·NCT01978483·31 enrolled

ALS1 trial

Analysis of Diphenylcyclopropenone (DPCP) in Normals

Completed·RRockefeller University··NCT01452594·30 enrolled

1 more indication

Skin Diseases1 trial

Role of Trem-1 in Ultraviolet Radiation-induced Immune Suppression

Active, not recruiting·UUniversity of Alabama at Birmingham·Phase 1·NCT05020496·70 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Diphenylcyclopropenone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Diphenylcyclopropenone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Diphenylcyclopropenone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Rockefeller University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: RRockefeller University

Related News